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Subfertility is encountered among some 15%
of all couples trying to conceive (Juul et al.
1999), and sperm counts in the subfertile range
are prevalent in some countries (Carlsen et al.
2005). Although advances in understanding of
causes and mechanisms have been made during
the past few decades (Aitken and Baker 2004;
DeMasters 2004; Sharpe 2003), major gaps in
knowledge still preclude effective prevention of
the majority of infertile cases. Lessons learned
from the occupational arena and indications of
contemporary declining trends and geographic
variation in the occurrence of male reproduc-
tive disorders have fueled the search for envi-
ronment- and lifestyle-related risk factors. The
hypothesis that ubiquitous man-made chemi-
cals in the environment may interfere with
proper development of reproductive organs
through interaction with natural hormonal reg-
ulation has achieved much attention (Toppari
2002). Proponents of the hypothesis focus on
a) an apparent decline of male reproductive
health and on evidence that several male repro-
ductive disorders are of fetal origin and may
share common causes (Skakkebaek et al.
2001); b) that similar developmental disorders
of male reproductive organs can be induced in
experimental studies after exposure to various
compounds that interfere with hormonal
homeostasis (Toppari 2002); and c) that
reproductive anomalies have been docu-
mented among sons of mothers treated during
pregnancy by the potent synthetic estrogen
diethylstilbestrol (Sharpe and Skakkebæk
1993). Opponents argue that the evidence on
major temporal shifts of, for example, sperm
counts, is circumstantial (Handelsman 2001)
and that the large number of xenobiotics
detectable in human tissues have low hor-
monal potencies (Daston et al. 1997) and
occur in concentrations far below levels that
conceivably could have a major impact on
reproductive organ development (Safe 2004).
Updated comprehensive reviews conclude that
current experimental and epidemiologic
evidence does not with sufﬁcient certainty sup-
port the view that environmental endocrine
disruptors contribute to an increase in male
reproductive disorders; neither does it provide
sufficient grounds to reject this hypothesis
(Storgaard et al. 2005; Vidaeff and Sever
2005). More recently, attention has shifted
from direct xenobiotic agonistic or antagonistic
actions on the human estrogen or androgen
receptor to interference with endogenous hor-
monal regulation (Sharpe and Irvine 2004).
Epidemiologic studies explicitly designed to
corroborate or refute the environmental hor-
mone hypothesis are few, but such studies are
important in providing reliable answers as to
whether xenobiotics are among important pre-
ventable causes of subfertility and other repro-
ductive disorders. From 2002 to 2005 a
European Union (EU) Fifth Framework
Programme Research and Development pro-
ject, INUENDO, was carried out explicitly to
address this deﬁcit in current knowledge. The
main ﬁndings have been published in a number
of focused original papers (Axmon et al. 2006;
Bonefeld-Jorgensen et al. 2006; Elzanaty et al.
2006; Giwercman et al. 2007; Giwercman AH
et al. 2006; Giwercman et al. 2006; Jönsson
et al. 2005; Kruger et al. 2007; Long et al.
2006, 2007; Spano et al. 2005; Stronati et al.
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OBJECTIVE: We synthesized the main ﬁndings from an international epidemiologic study on the
impact of biopersistent organic pollutants (POPs) on human reproductive function.
DATA SOURCES AND EXTRACTION: We used a database with interview and biological data from
2,269 women and their spouses, and 18 published core papers.
DATA SYNTHESIS: The study did not provide direct evidence of hormone-like activity of the poly-
chlorinated biphenyl (PCB) congener CB-153 and the main dichlorodiphenyltrichloroethane
(DDT) metabolite, 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (p,p´-DDE), as serum concentra-
tions of these compounds were not consistently related to either endogenous or exogenous hor-
mone activity in serum. Nevertheless several links bewteen POP exposure and biomarkers of male
reproductive function were identiﬁed. First, an association between high CB-153 serum levels and
low sperm counts was detected within a subgroup of men with short androgen receptor CAG
repeat length. Second, a relationship between increased CB-153 serum concentrations and
decreased sperm motility was seen in all four studied regions, and indications of reduced neutral
α-glucosidase activity in seminal plasma point to a post-testicular effect. Third, damage of sperm
chromatin integrity was considerably less frequent in Greenlandic Inuits compared with that in
European groups, and only in the latter was impairment of sperm chromatin integrity related to
POPs. Despite these effects, fertility in terms of time taken to conceive was not related to POPs
except in Inuits. A likely explanation of the latter was not identiﬁed. 
CONCLUSIONS: POPs may interfere with male reproductive function without major impact on fer-
tility. The data do not provide direct evidence for endocrine disruption, hence other mechanisms
should also be considered.
KEY WORDS: Inuit, polymorphisms, reproductive health, semen quality, sex hormone receptors, time
to pregnancy, xenobiotics. Environ Health Perspect 116:269–277 (2008). doi:10.1289/ehp.10700
available via http://dx.doi.org/ [Online 23 November 2007]2006; Tiido et al. 2006; Toft et al. 2004,
2005a, 2005b, 2006, 2007). The purpose of
this article is to provide an overview of the main
results that emerged from the INUENDO pro-
ject and to review the ﬁndings relative to the
overall evidence on persistent organic pollutants
(POPs) and human fertility. 
Methods
The INUENDO studies combine four inter-
view studies of time to pregnancy (TTP) with
four cross-sectional studies of male reproduc-
tive hormones and semen quality (Table 1).
Three study populations included pregnant
women and their male spouses who had ante-
natal care visits from May 2002 through
February 2004 at one of three locations:
a) the local hospitals in 19 cities and settle-
ments throughout Greenland, b) a large cen-
tral hospital in Warsaw, Poland, and c) three
hospitals and eight antenatal clinics in
Kharkiv, Ukraine. A fourth study population
included Swedish fishermen and fishermen’s
wives. They were enrolled independent of
current pregnancy in two separate steps from
an existing cohort (Rignell-Hydbom et al.
2004; Rylander et al. 1995). A total of 2,269
women from the four localities were enrolled
(participation rates 26–90%; Table 1). In
Greenland, Kharkiv, and Sweden, the age dis-
tribution and the number of children did not
differ between participants, those who
declined participation, and nonrespondents.
Available data did not allow for nonresponse
analysis in the Polish sample (Toft et al.
2005a). Male spouses were consecutively
encouraged to participate in a semen study
until approximately 200 men at each site had
agreed (participation rates 7–79%; Table 1).
The low particpation rate among Swedish
fishermen (7%) is due to the more elderly
study population and the recruitment proce-
dure that involved postal correspondence in
several consecutive steps.
Information on TTP for the current (the
three pregnancy–based cohorts) or the latest
planned pregnancy (the Swedish population–
based cohort) was obtained by in-person inter-
views with the women at the hospital or resi-
dence or by telephone (Sweden) using a
structured questionnaire (Toft et al. 2005a).
The male partners provided separate interview
data on lifestyle factors, urogenital disorders,
and infertility that were used to describe repro-
ductive characteristics of couples, with men
providing or not providing semen samples
(Toft et al. 2005a). Finally, women and men
had a venous blood sample drawn (Table 1). 
Polychlorinated biphenyls (PCBs) and the
dichlorodiphenyltrichloroethane (DDT)
metabolite 1,1-dichloro-2,2-bis(p-chloro-
phenyl)-ethylene (p,p´-DDE) were selected as
biomarkers of exposures of interest because of
documented hormonal actions (Bonefeld-
Jorgensen et al. 2001; Kelce et al. 1997;
Moore et al. 1997), widespread occurrence
worldwide (Bignert et al. 1998), and existence
of reliable and relatively inexpensive assays
suitable for large-scale epidemiologic studies.
2,2´,4,4´,5,5´-Hexachlorobiphenyl (CB-153)
was selected as a marker of PCB congeners
because it correlated well with both total PCB
concentration in plasma and serum from
Swedish subjects and Inuits from Greenland
(Glynn et al. 2000; Grimvall et al. 1997) and
with the 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD) equivalent (TEQ) in plasma from
PCB as well as the total POP-derived TEQ in
plasma in American Vietnam veterans (Gladen
et al. 1999). The antiandrogenic compound
p,p´-DDE, the major metabolite of the insecti-
cide DDT was selected as a supplementary
marker of POP exposure. Moreover, xeno-
hormone activity in serum cleared for endoge-
nous hormones and dioxin-like activity in the
lipid fraction of serum was measured in a sub-
set of the study population by ex vivo chemical-
activated luciferase gene expression (CALUX)
assays. Reporter gene constructs and cell cul-
ture systems were used to explore whether inte-
grated measures of xenobiotic receptor binding
are related to reproductive end points. The
luciferase activity was expressed as relative light
units (RLUs) per milliter serum; reference lev-
els were calculated to 3.31 RLU/mL serum
[estrogen receptor (ER), androgen receptor
(AR)] and 6.67 RLU/mL serum [aryl hydro-
carbon receptor (AhR)]. For details, the reader
is referred to original papers (Bonefeld-
Jorgensen et al. 2006; Kruger et al. 2007; Long
et al. 2006). An overview of biological markers
of male reproductive function investigated in
the present study is given in Table 1. 
The ﬁne tuning of the AR function is reg-
ulated by two polymorphic sequences in the
transactivating part of the receptor, namely,
polyglutamine-encoding CAG repeats and
polyglycine-encoding GGN triplets (Gao
et al. 1996; Tut et al. 1997). Earlier studies
have indicated that the number of CAG
repeats and the GGN triplets can influence
the functional status of the AR. Analyses of
interactive effects of AR polymorphisms were
performed to provide clues as to causal infer-
ence and insight into possible mechanisms
(Giwercman et al. 2007). For these analyses
CAG repeat numbers were categorized into
ﬁve groups of almost equal size: < 20, 20/21,
22/23, 24, and > 24.
Data analysis. To create an overview of
the cross-sectional relations between POP
exposure and all reproductive end points and
to enable a systematic and coherent assess-
ment of strength, exposure response, and
internal consistency of associations, we sum-
marized the data using a simpliﬁed, uniform
approach building on comprehensive statisti-
cal analyses in previous papers (Table 1).
Common risk estimates. We present data
at the aggregated level across all regions unless
inappropriate because of heterogeneous asso-
ciations. Heterogeneity was examined by
interaction terms in multiple regression mod-
els. However, because the frequency of gene
Bonde et al.
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Table 1. The INUENDO study populations and measures of exposures and outcomes.
Pregnant women and spouses
attending antenatal care, 2002–2004
Populations, exposure  Warsaw, Kharkiv, Fishermen’s Fishermen,
measures, and end points Poland Ukraine Greenland wives, Sweden Sweden All
Eligible target populations 690 2,478 665 1,439 2,783 8,055
Enrolled couples  472 (68%) 640 (26%) 598 (90%) 559 (35%) — 2,269 (28%)
Blood samples, POPs
(CB-153 and p,p´-DDE)
Women 261 614 573 544 — 1,992
Men 257 287 440 — 189 1,172
Male hormones 144 215 325 190 874
CALUX
Estrogen 99 89 74 100 362
Androgen 83 83 37 59 262
Dioxin-like 99 87 75 78 339
Eligible men addressed 690 640 256 2,783 4,369
for the semen studies
Semen samples
WHO 198 208 198 191 798
CASA 165 0 200 179 542
SCSA 143 208 200 184 736
TUNEL 134 134 195 166 634
APOPTOSIS 132 142 161 161 630
Y/X-SPERM 122 133 184 155 571
Accessory sex glands 187 203 184 158 732
Abbreviations: APOPTOSIS, percentage of ejaculated sperm cells expressing the Fas protein, as an indicator of apopto-
sis, and the Bcl-xL antigen, as an indicator of anti-apoptosis (Stronati et al. 2006); CALUX, chemical-activated luciferase
gene expression; CASA, computer-aided sperm analysis; SCSA, sperm chromatin structure assay; TUNEL, terminal
deoxynucleotidyl transferase dUTP nick end-labeling; WHO (World Health Organization), sperm count, morphology and
motility measured according to the WHO 1999 guidelines (WHO 1999); Y/X SPERM, ratio between ejaculated spermatozoa
with Y and X sex chromosome.polymorphisms regulating male reproduction
seems to differ substantially between Inuits
and Europeans (Giwercman et al. 2007), all
analyses were stratiﬁed accordingly. With this
approach, effect modification by European
regions may be hidden, but region-specific
associations are presented comprehensively in
the core articles. 
Exposure categorization. Central meas-
ures of distributions in terms of medians and
corresponding adjusted geometric mean val-
ues are presented according to exposure levels
divided into three intervals. Cutoff values
were selected as trade offs between numbers
in each category, contrast of exposure, and
ranges within each interval for CB-153 (ng/g
lipid): 0–100, 101–200, and > 200 (highest
value 5,460); and for p,p´-DDE (ng/g lipid):
0–500, 501–1,000, and > 1,000 (highest
value 13,200). 
Xenobiotic CALUX values were dichoto-
mized into values above and below the average
reference value of 3.13 RLU/mL serum for ER
and AR assays and 6.67 RLU/mL serum for
the AhR assay. For the agonistic assays, higher
CALUX values indicate agonistic transactiva-
tion, and for the competitive assays, higher val-
ues indicate enhanced (synergistically or
additively) transactivation of the natural or
synthetic ligands and lower values indicate an
antagonistic effect on ligand-induced receptor
transactivation (Bonefeld-Jorgensen et al.
2006; Kruger et al. 2007; Long et al. 2006). 
Statistical methods. The distribution of
hormonal and semen characteristics in each
exposure category was compared with the refer-
ence category by multiple linear regression. In
addition, tests for linear trends across the entire
exposure range were performed by similar
methods but with exposure entered as a contin-
uous variable. With few exceptions, end points
were transformed by the natural logarithm to
normalize skewed distributions as described in
the core articles. In linear trend analyses, the
exposure variables were also transformed by the
natural logarithm to account for the higher
variability in the high end of the distribution.
Adjustments for potential confounding vari-
ables included only a few well-established deter-
minants, which were included regardless of
effects in the present data set. These determi-
nants are listed in Table 2 (footnotes).
Comprehensive confounder analysis according
to the change in estimate method is provided in
the core articles. The parsimonious approach
we use here and the comprehensive approach
applied in the core articles resulted essentially in
similar ﬁndings and, if not, deviances are explic-
itly addressed. Geometric mean values and their
confidence intervals (CIs) were obtained by
back transformation, whereas linear regression
coefficients in analyses based on continuous
exposure variables were not. All summary
analyses presented in this article were per-
formed using SAS 9.13 software (SAS Institute
Inc, Cary, NC, USA).
Systematic criteria used to help distin-
guish spurious from causal associations.
A priori hypotheses declared before the execu-
tion of the project were held in general terms.
Therefore, most of the several hundred com-
parisons that have been performed should be
considered explorative, and the risk of spuri-
ous associations regardless of statistical signiﬁ-
cance testing may be high. Evaluation of
consistency of ﬁndings across regions includ-
ing assessment of strength (magnitude) of
associations and exposure–response relation-
ships has been performed throughout. 
Results
Exposure levels. The blood measurements of
POP markers in men and women demon-
strated large variations between and within
study populations (Figure 1) (Jönsson et al.
2005). The median serum concentrations of
the most abundant PCB congener, CB-153 as
well as the DDT metabolite p,p´-DDE varied
> 10-fold between regions. The within-region
ranges of the 5th and 95th percentiles were of
similar magnitude.
The INUENDO project is the ﬁrst large-
scale population-based epidemiologic study that
INUENDO summary review
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Table 2. Adjusted geometric mean values and linear regression coefficients of male reproductive hormones in serum, semen characteristics, and markers of
epididymal and accessory sex gland function by categories of CB-153.
Inuits Europeans
CB-153 (ng/g lipid) CB-153 (ng/g lipid) Inuits Europeans
0–50 51–200 > 200 0–50 51–200 > 200 Linear regression coefﬁcient (95% CI)
n = 10 n = 80 n = 104 n = 300 n = 182 n = 87 n = 194 n = 763 
Male reproductive characteristics (n = 19) (n = 150) (n = 145) (n = 256) (n = 183) (n = 91) (n = 314) (n = 530)
Male reproductive hormones in seruma,b
Follicle-stimulating hormone (IU/L) 4.2 4.1 4.5 3.9 4.3 4.8 0.04 (–0.02 to 0.1) 0.0008 (–0.06 to 0.07)
Luteinizing hormone (IU/L) 3.1 3.9c 4.1c 3.7 4.0 3.7 0.07c (0.02 to 0.12) –0.02 (–0.08 to 0.04)
Inhibin B (ng/L) 160 170 182 184 182 165 6.6 (–2.1 to 15.2) –4.4 (–13 to 4)
Sex hormone–blinding globulin (mmol/L) 28 29 29 25 31c 32c 0.6 (–0.6 to 18) 2.1c (0.7 to 35)
Free testosterone 1.63 1.73 1.75 1.87 1.68c 1.65c 0.01 (–0.01 to 0.04) –0.05c (–0.08 to –0.02)
Conventional semen characteristics
Volume (mL)d,e 4.3 3.4 3.0c 3.1 3.6 3.3 –0.11c (–0.2 to –0.04) 0.01 (–0.05 to 0.08)
Concentration (million/mL)e 58 52 53 46 53 64 0.03 (–0.1 to 0.2) 0.2 (0.0 to 0.2)
Count (million)d,e 229 274 149 142 185 200 –0.1 (–0.3 to 0.1) 0.1 (–0.0 to 0.2)
Normal sperm (%) 8.0 5.9 5.9 6.2 5.8 5.3 –0.0 (–0.1 to 0.1) –0.0 (–0.1 to 0.1)
Progressive sperm (%)e,f 65 57 53c 60 57 51c –4c (–6 to –1) –4c (–6 to –1)
Sperm chromatin integrityb,e
DNA fractionation index (%DFI) 8.0 7.6 7.5 9.9 12.8c 15.4c –0.0 (–0.1 to 0.1) 0.2c (0.1 to 0.2)
High DNA stainability (%HDS) 6.6 12.6c 11.0c 9.0 9.3 8.9 0.0 (–0.1 to 0.1) –0.0 (–0.1 to 0.1)
DNA fractionation index [TUNEL (%)] 3.5 3.2 2.6 7.7 10.7c 12.0c –0.1 (–0.3 to 0.0) 0.2c (0.0 to 0.3)
Apoptotic markersb,e
Fas positivity (%) 22.3 16.6 17.6 17.3 16.3 21.6 0.0 (–0.1 to 0.2) –0.1 (–0.3 to 0.2)
Bcl-xL positivity (%) 12.7 12.6 10.3 16.6 16.6 20.6 –0.1 (–0.4 to 7.7) 0.4c (0.1 to 0.7)
Epididymal and accessory sex gland functionb,d,e
Neutral α-glucosidase (mU/ejaculate) 25.0 16.6c 15.7c 18.5 26.8c 24.8c –0.1c (–0.2 to –0.0) 0.1 (–0.0 to 0.2)
Prostate-speciﬁc antigen (µg/ejaculate) 8.6 8.0c 8.0c 7.9 8.1c 7.9 –0.1 (–0.2 to 0.0) 0.0 (–0.1 to 0.1)
Zinc (µmmol/ejaculate) 6.6 4.8 4.2 4.5 5.9 5.1 –0.1 (–2.1 to 1.4) 0.0 (–0.1 to 0.1)
Fructose (µmmol/ejaculate) 71 43 44 38 44 35 –0.1 (–0.2 to 0.0) –0.0 (–0.1 to 0.1)
Abbreviations: %DFI, percentage of sperm with denaturable DNA, mainly due to DNA damage (Spano et al. 2000); %HDS, percentage of sperm with high levels of green ﬂuorescence,
indicating immature sperm (Spano et al. 2000); n, number of semen samples; (n =), number of blood samples (analysis of reproductive hormones); TUNEL, terminal deoxynucleotidyl
transferase dUTP nick end-labeling. All analyses among Europeans were adjusted for study group (Warsaw, Kharkiv, and Sweden). 
aAdjustment by time of blood sampling (0800–1200 hours: yes/no). bAdjustment by the logarithm of age (years). cMean values and linear regression coefﬁcents associated with a p-value
< 0.05 [exposed vs. reference group (CB-153, 0–50 ng/g lipid)]. dSamples with spillage were excluded. eAdjustment by the logarithm of period of abstinence (day). fSamples with a delay
of > 1 hr from collection were excluded.has evaluated the integrated xenohormone (ER,
AR) and dioxin-like (AhR) activity in serum by
CALUX assays (Bonefeld-Jorgensen et al. 2006;
Kruger et al. 2007; Long et al. 2006). These
assays demonstrated agonistic as well as com-
petitive receptor interference of serum cleared
for endogenous hormones, although the
between- and within-region variation was small
compared with variations in POP concentra-
tions (Figure 2). The CALUX activities were
only weakly correlated with CB-153 and
p,p´-DDE, indicating that these organo-
chlorines are not the important contributors to
the measured xenobiotic serum activity. 
Reproductive end points according to
polychlorinated biphenyls (CB-153) and
p,p´-DDE. Fecundability measured by TTP in
couples that conceived was not related to
CB-153 among Europeans, but among Inuits
the fecundability was reduced among interme-
diate- and high-level exposed men and women
compared with those exposed to low levels of
CB-153, although no obvious exposure–
response relations were found and ﬁndings were
of borderline signiﬁcance (Axmon et al. 2006).
The risk associated with male exposure was
most likely not confounded by female exposure
and vice versa, but because of the strong corre-
lation between CB-153 and p,p´-DDE among
Inuits, it was not possible to determine if the
risk was associated with CB-153 or p,p´-DDE
or an interaction between the two compounds.
None of the five male reproductive hor-
mones measured in serum varied consistently
with CB-153 serum levels among Inuits and
Europeans, but luteinizing hormones increased
with increasing CB-153 among Inuits and free
testosterone decreased, whereas sex hormone–
binding globulin levels became higher with
increasing CB-153 among European men
(Table 2). Comprehensive additional analyses
of reproductive hormones within each region
indicated several endocrine responses associ-
ated with CB-153 blood levels in some regions
but not in others (Giwercman AH et al. 2006).
Sperm count and the proportion of mor-
phologically normal sperm was not related to
CB-153 in any study group, but progressive
sperm motility was inversely related to
CB-153 in serum among both Inuits and
Europeans, with consistent indications of
exposure response relationships (Table 2; Toft
et al. 2006). The percentage of progressively
motile sperm decreased by 3.6% (95% CI,
1.7–5.6) per 1 U increase in the logarithm of
serum CB-153 (nanograms per gram lipid) in
the entire data set (Toft et al. 2006). 
We observed signiﬁcant interactive effects
of CB-153 and AR CAG repeats on sperm
counts but not on semen volume, sperm
motility, or sperm morphology (Giwercman
et al. 2007). Thus, when total sperm number
was compared in men with CB-153 levels
above median and those with exposure below
median, sperm output was 40% lower in sub-
jects with AR CAG repeat length < 20 but not
in those with ≥ 20 repeats. 
Two independent indicators of sperm
chromatin integrity [% DNA fragmentation
index (%DFI) and terminal deoxynucleotidyl
transferase dUTP nick end-labeling (TUNEL)]
were strongly related to CB-153 serum levels
among Europeans but not among Inuits
(Table 2; Spano et al. 2005; Stronati et al.
2006). Among Europeans the proportion of
sperm with impaired sperm chromatin
integrity increased with increasing CB-153
blood concentrations to a level almost double
that in the high-level-exposed group. This asso-
ciation seemed not to be confounded by con-
comitant exposure to p,p´-DDE. Our study
failed to demonstrate any relation between
CB-153 and apoptotic sperm biomarkers (Fas
and Bcl-xL) in any region or overall (Stronati
et al. 2006). No interactive effects of AR poly-
morphisms and CB-153 on %DFI were found
(Giwercman et al. 2007). 
Associations between CB-153 and the
proportion of Y spermatozoa exhibited strong
heterogeneity across regions (Tiido et al.
2006). In the Swedish fishermen cohort,
CB-153 serum levels were positively associ-
ated with the proportion of Y chromosome–
bearing spermatozoa [linear regression coefﬁ-
cient β = 0.53 (95% CI, 0.001 to 1.05)],
whereas among Polish men, levels of CB-153
correlated negatively with the proportion of
Y sperm [β = –0.54 (95% CI, –0.92 to
–0.14)]. The difference in average proportion
Y-bearing sperm between these groups was
small (51.2% for the fishermen sample,
50.3% for the Polish sample).
None of several seminal markers of epi-
didymal and accessory sexual gland function
varied consistently with CB-153 serum levels
among Inuits or Europeans across all regions
(Table 2; Elzanaty et al. 2006). However, a
statistically significant negative association
between the levels of CB-153 and the total
activity of NAG was seen among men from
Greenland and Warsaw and in the entire data
set (Elzanaty et al. 2006). Moreover, NAG
was also lower in high-level-exposed Swedish
fishermen, whereas in Kharkiv, higher levels
of CB-153 tended to be related to higher lev-
els of NAG. Associations between serum con-
centrations of p,p´-DDE and reproductive
end points are given in Table 3. 
Reproductive end points in relation to ER,
AR, and AhR CALUX serum activity. In the
subset of couples with valid TTP data and male
CALUX activity data (n = 182), no consistent
indications were found across regions of deviat-
ing fecundability according to ER, AR, or AhR
Bonde et al.
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Figure 1. Box plots showing lipid-adjusted serum concentrations of CB-153 and p,p’-DDE (ng/g serum lipid)
in men (A, B) and women (C, D) in four regions. Values shown are median (line within box), 25th and 75th
percentiles (bottom and top of box, respectively), 5th and 95th percentiles (lower and upper bars on
whisker, respectively), and outliers (circles). Numbers below region labels indicate numbers of men or
women who provided blood samples.
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PopulationCALUX assay activity. Moreover, sperm count,
morphology, and motility were not related to
agonistic, competitively enhanced, or antago-
nistic estrogenic serum activity across all regions
or—with few exceptions—in any of the regions
(Tables 4 and 5). Similar negative ﬁndings were
observed for the AR and AhR CALUX meas-
urements (data not shown). Summary ﬁndings
with respect to other seminal characteristics are
given in Tables 4 and 5 for the ER CALUX
assays (data for other assays not shown).
Comprehensive analyses of correlations
between ER as well as AR and AhR xenobiotic
activities and semen characteristics, including
indicators of sperm DNA damage and abnor-
mal sperm apoptosis, did not reveal consistent
patterns of associations across regions. For
details, the reader is referred to the original
articles (Long et al. 2007; Toft et al. 2007).
Discussion
Reports on secular trends in male reproductive
health in the early 1990s became a major
impetus for research on the hypothesis that
male reproductive disorders may be related to
xenobiotics with hormone-like properties. Two
recent systematic reviews reexamined the evi-
dence on the importance of xenohormone
exposure in human reproductive health. Both
reviews emphasize the current lack of explicit
epidemiologic observations to validate the
hypothesis (Storgaard et al. 2005; Vidaeff and
Sever 2005). The purpose of the INUENDO
project was to contribute additional insight
into links between putative xenohormonal
dietary exposure, as measured by POP markers
in blood, and human fertility, as measured by
an array of functional and biological indicators.
To accomplish this objective approximately
5,000 women and spouses were enrolled in
four cohorts in Greenland, northern, central,
and eastern Europe. Below we discuss the
coherence and synthesis of the main ﬁndings. 
Endocrine disruption. Experimental data
have shown weak hormonal activity of the PCB
congener CB-153 and the main DDT metabo-
lite p,p´-DDE (Bonefeld-Jorgensen et al. 2001;
Kelce et al. 1995; Moore et al. 1997), but our
study does not provide strong or consistent evi-
dence that these POP markers express hor-
mone-like activity in humans at the prevailing
exposure levels. Thus, the serum POP concen-
trations were not consistently related to either
serum concetrations of sex hormones or to
exogenous CALUX activities of serum across all
study populations. However, an association
between the concentration of p,p´-DDE in
male serum and sex hormones in blood was
observed in the Kharkiv region (Giwercman
AH et al. 2006). Moreover, a weak increase in
follicle-stimulating hormone with increasing
CB-153 was observed in all regions but did not
reach statistical signiﬁcance in the pooled analy-
sis. Whether these results have any bearing on
impaired male reproductive function is not
clear. One interpretation is that associations
between POP and sex hormones are heteroge-
neous because of heterogeneous xenobiotic
exposure that is only partly reflected by the
POP markers measured in the present study.
This is to some extent supported by the xenobi-
otic CALUX activities showing regional varia-
tion and weak correlations with POP markers.
Another possibility is spurious associations
emerging from a great number of explorative
comparisons that have been carried out or
uncontrollable bias inherent in study design
and data collection. Because of the lack of
strong and consistent associations, it is not pos-
sible to distinguish these different interpreta-
tions. But it should be kept in mind that
cross-sectional associations based on point
measurements of plasma concentrations of sex
hormones reﬂect dynamic time-varying interac-
tions and compensatory feedback mechanisms
to a limited degree. Thus, no strong negative
conclusions on the effect of POPs on hormonal
homeostasis can be made from these ﬁndings. 
Post-testicular effetcs of POPs. In the pre-
sent study, progressive sperm motility
decreased with increasing POP blood levels in
all four regions and seemed strongest among
Inuits with rather high exposure to both POP
markers. This finding is consistent with the
results of six of seven cross-sectional studies
(Aneck-Hahn et al. 2007; Dallinga et al.
2002; Danadevi et al. 2003; de Jager et al.
2006; Guo et al. 2000; Richthoff et al. 2003;
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Figure 2. Box plots showing estrogenic (A, B), androgenic (C, D), and aryl hydrocarbon (dioxin-like, AhR; E, F)
CALUX activities among men in four regions. For each receptor, agonistic assays are displayed on left panels
(A, C, E) and competitive assays are displayed on right panels (B, D, F). Values shown are median (line within
box), 25th and 75th percentiles (bottom and top of box, respectively), 5th and 95th percentiles (lower and
upper bars on whisker, respectively), and outliers (circles). The dotted horizontal lines indicate the reference
line. For agonistic assays, the reference line is solvent contol activity. For competitive assays, the reference
line indicates competitive activity upon co-exposure to the natural (17β-estradiol) or synthetic ligands (the
AR agonist R1881 and the AhR agonist TCDD) at a concentration of 40–50% of the concentration eliciting
maximal response according to the assay-speciﬁc calibration curve (EC40–50). For competitive assays, values
above the reference line indicate enhancement of ligand activity and values below the line indicate competi-
tive inhibition. Numbers below region labels indicate number of male measurements.
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AntagonizingRozati et al. 2002). The two most recent stud-
ies carried out in Mexico and South Africa
enrolled men with high environmental expo-
sures and both demonstrated strong associa-
tions between serum concentrations of
p,p´-DDE and various measures of sperm
motility. Additional supportive evidence
comes from two adult rat studies reporting
reduced sperm motility after treatment with
high doses of coplanar as well as noncoplanar
PCBs (Hsu et al. 2003, 2004). Interestingly,
the non-coplanar PCB congeners (CB-132
and CB-149) only affected sperm motility,
whereas the coplanar dioxin-like PCB con-
gener CB-77 also reduced sperm counts. The
immotile testicular spermatozoa are gaining
motility through slow passage through the epi-
didymal tubules. Once ejaculated, secretions
from the seminal vesicle and the prostate play
a crucial role in energy supplies and composi-
tion of the seminal fluid and thereby in the
ability of the spermatozoa to move (Elzanaty
et al. 2006). Considering the consistent associ-
ations between CB-153 and sperm motility, it
is of interest that NAG decreased with increas-
ing CB-153 serum levels (but not p,p´-DDE
serum levels), which is fairly consistent across
the four regions (Elzanaty et al. 2006). NAG
is excreted by the caudal part of the epi-
didymis and is widely used as a marker of epi-
didymal function in the clinical setting—low
seminal levels, indicating impaired excretion
and reduced epididymal function. Little is
known about the physiologic role of the
enzyme, but our study and an earlier study by
Richthoff et al. (2002) show that NAG is
weakly correlated with percentage motile
sperm. For other seminal markers of epididy-
mal and accessory sex gland function, ﬁndings
were less consistent across regions.
Sex hormones regulate epididymal and
accessory sex gland function. These organs
express the estrogen, androgen, and the aryl
hydrocarbon receptors. Some PCB congeners
bind to the ER and AhR and elicit agonistic or
antagonistic activity in vitro. Moreover, syn-
thetic estrogens such as diethylstilbestrol and
antiestrogens such as tamoxifen reduce epi-
didymal and accessory sex gland weight when
administered to adult rats in high doses
(Elzanaty et al. 2006). However, as discussed
above, this present study does not provide any
explicit support for the assumption of
endocrine disruption as the basic mechanism
of action. Polymorphisms in the AR gene did
not modify POP-related effects on sperm
motility (Giwercman et al. 2008), and none of
the CALUX activities that are assumed to rep-
resent the integrated xenohormone action
from the mixture of pollutants in the serum
extracts were consistently related to sperm
motility across study populations. In addition,
it can be argued that the estrogenic and andro-
genic equivalents contributed by xenobiotics
in these highly exposed populations only are a
few percent of the endogenous hormone activ-
ity, even when possible higher bioavailability
of the xenobiotics is taken into consideration
(Toft et al. 2007). However, in controlled
rodent experiments, effects on reproductive
function have been observed at very low expo-
sure levels, particularly after exposure during
the fetal and postnatal development periods
(Anas et al. 2005; Mably et al. 1992)—an
issue not explicitly addressed by this project.
Thus, the picture with respect to mechanisms
at the cellular level is far from clear, and the
possibility cannot be excluded that POPs also
exert toxic effects independent of hormonal
actions. There is therefore a need for further
research into the impact of POPs on epididy-
mal function and gene expression. 
Gene–environment interaction. There are
several earlier human studies on the effects of
postnatal POP exposure on testicular func-
tion. In the study with subjects with the high-
est exposure to PCBs and polychlorinated
dibenzo-p-dioxins after the Yucheng accident
in Taiwan, abnormal sperm morphology and
reduced sperm capacity to penetrate hamster
eggs were found (Hsu et al. 2003). Two recent
large cross-sectional studies of men with high
environmental exposure to DDT in Mexico
Bonde et al.
274 VOLUME 116 | NUMBER 3 | March 2008 • Environmental Health Perspectives
Table 3. Adjusted geometric mean values and linear regression coefﬁcients of male reproductive hormones in serum, semen characteristics, and markers of epi-
didymal and accessory sex gland function by categories of p,p´-DDE.
Inuits Europeans
p,p´-DDE (ng/g lipid) p,p´-DDE (ng/g lipid) Inuits Europeans
0–500 501–1,000 > 1,000 0–500 501–1,000 > 1,000 Linear regression coefﬁcient (95% CI)
n = 82 n = 50 n = 62 n = 260 n = 188 n = 121 n = 194 n = 763
Outcome (n = 155) (n = 80) (n = 78) (n = 236) (n = 177) (n = 117) (n = 314) (n = 530)
Male reproductive hormones in seruma,b
Follicle-stimulating hormone (IU/L) 4.5 4.3 4.2 3.8 4.3 4.5c 0.03 (–0.02 to 0.08) 0.06 (–0.01 to 0.14)
Luteinizing hormone (IU/L) 4.2 3.8 3.8 3.7 3.8 4.3c 0.05c(–0.01 to 0.01) 0.05 (–0.01 to 0.11)
Inhibin B (ng/L) 181 177 170 189 177 166c 6.4 (1.7 to 13.8) –13c (–4 to –23)
Sex hormone–binding globulin (mmol/L) 28.2 29.0 29.1 26.3 28.3 30.8c 0.08 (–1.0 to 1.1) 1.3 (–0.3 to 2.8)
Free testosterone 1.79 1.72 1.70 0.59 0.57 0.55 0.02c (0.0 to 0.04) –0.02 (–0.05 to 0.01)
Conventional semen characteristics
Volume (mL)d,e 2.8 3.2 3.5c 3.3 3.3 3.1 0.04 (–0.16 to –0.01) –0.03 (–0.1 to 0.04)
Concentration (million/mL)e 55 51 52 49 53 58 –0.05 (–0.08 to 0.16) 0.14c (0.02 to 0.27)
Count (million)d,e 150 150 180 165 165 160 –0.01 (–0.2 to 0.1) 0.12 (–0.03 to 0.27)
Normal sperm (%) 6.3 5.1 6.3 6.0 5.7 6.1 –3.2c (–0.1 to 0.1) 0.03 (–0.09 to 0.15)
Progressive sperm (%)e,f 51 54 59c 59 57 55 –0.01 (–0.5.9 to -0.6) –2.3 (–5.2 to 0.7)
Sperm chromatin integrityb,e
DNA fractionation index (%DFI) 7.9 7.3 7.5 11.3 11.7 12.0 –0.01 (–0.1 to 0.1) 0.1 (–0.0 to 0.2)
High DNA stainability (%HDS) 10.2 12.6 11.5 9.3 8.7 9.3 0.01 (–0.1 to 0.1) –0.02 (–0.1 to 0.1)
DNA fractionation index [TUNEL (%)] 3.9 4.3 4.3 9.3 9.2 9.5 –0.04 (–0.1 to 0.1) 0.0 (–0.1 to 0.2)
Apoptotic markersb,e
Fas positivity (%) 18.3 19.0 17.7 16.9 17.4 19.9 –0.02 (–0.2 to 0.1) 0.2 (–0.1 to 0.4)
Bcl-xL positivity (%) 13.1 11.5 13.1 19.2 13.9 24.1 –0.03 (–0.3 to 0.1) 0.13 (–0.2 to 0.5)
Epididymal and accessory sex gland functionb,d,e
Neutral α-glucosidase (mU/ejaculate) 14.9 18.2 16.7 20.9 20.6 23.3 –0.05 (–0.1 to 0.1) –0.0 (–0.1 to 0.1)
Prostate-speciﬁc antigen (µg/ejaculate) 2,930 3,270 3,210 2,940 2,550 3,000 –0.04 (–0.1 to 0.1) –0.0 (–0.1 to 0.1)
Zinc (µmmol/ejaculate) 4.0 4.8 4.7 5.3 4.5 5.2 –0.01 (–0.2 to 0.1) 0.0 (–0.1 to 0.1)
Fructose (µmmol/ejaculate) 39 53 45 38 40 40 –0.05 (–0.2 to 0.1) –0.0 (–0.2 to 0.1)
Abbreviations: %DFI, percentage of sperm with denaturable DNA, mainly due to DNA damage (Spano et al. 2000); %HDS, percentage of sperm with high levels of green ﬂuorescence,
indicating immature sperm (Spano et al. 2000); n, number of semen samples; (n =), number of blood samples (analysis of reproductive hormones); TUNEL, terminal deoxynucleotidyl trans-
ferase dUTP nick end-labeling. All analyses among Europeans were adjusted for study group (Warsaw, Kharkiv, and Sweden).
aAdjustment by time of blood sampling (0800–1200 hours: yes/no). bAdjustment by the logarithm of age (years). cMean values and linear regression coefﬁcents associated with a p-value
< 0.05 [exposed versus reference group (CB-153, 0–50 ng/g lipid)]. dSamples with spillage were excluded. eAdjustment by the logarithm of period of abstinence (day). fSamples with a
delay of > 1 hr from collection were excluded.and South Africa failed, however, to demon-
strate associations between serum concentra-
tions of p,p´-DDE and sperm concentrations,
whereas effects on semen volume and total
sperm were found in one study (Aneck-Hahn
et al. 2007) but not in another (de Jager et al.
2006). The lipid-adjusted serum concentra-
tions were approximately 50–200 times higher
in these groups of men than in men in our
study. These ﬁndings seem consistent with the
results in the present study where neither
sperm count nor sperm morphology was
related to POP exposure in any of the four
study groups. However, among the subset of
men with short AR CAG repeat length, which
makes up about one-ﬁfth of the entire study
population, high levels of CB-153 were signif-
icantly related to low levels of sperm counts
(Giwercman et al. 2007). This observation is
an indication of gene–environment interaction
between POPs and AR configurations. We
acknowledge, however, that this finding
emerges from a pooled analysis of four diverse
study groups and calls for independent replica-
tion. The mechanism by which the CAG
repeat length might modify the effect of POP
on semen characteristics is not known.
However, as the three-dimensional structure
of the receptor is affected by the length of the
CAG stretch, one could hypothesize that the
strength of the POP binding, or of any neces-
sary co-factor, is regulated by CAG number
(Giwercman et al. 2007). 
The INUENDO studies also indicate inter-
active effects on sperm chromatin integrity,
although not necessarily gene–exposure interac-
tions. The sperm chromatin structure assay
measures two different types of sperm chro-
matin anomalies, one linked to DNA damage
(%DFI) and the other reﬂecting abnormal con-
densation of proteins during the tight packag-
ing of the sperm DNA (%HDS). Both types of
chromatin anomalies are traced indirectly by
in situ acid denaturation of sperm cells.
Independent of sperm count, morphology, and
motility, %DFI is related to male fertility,
which starts decreasing when the percentage of
abnormal sperm cells increases above approxi-
mately 20% (Spano et al. 2000). The %DFI
measure is rather stable within subjects, and a
number of studies of several European popula-
tions have shown remarkably homogenous dis-
tributions (Spano et al. 1998). Therefore, it is
interesting that the %DFI levels were lower in
Inuit men, indicating more “healthy” sperm
chromatin. The sperm TUNEL assay demon-
strated even more pronounced low levels of
sperm DNA damage in Inuits. Comparable
data have to our knowledge not been published
previously. The low frequency of chromatin
damage among Inuits, as demonstrated by two
independent assays, could be genetic in origin,
although dietary constituents as polyunsatu-
rated fatty acids and selenium could also play a
role. Interestingly, high serum concentrations of
CB-153 were strongly related to low sperm
integrity among European men, but there was
no association among Inuit men. That exposure
to POPs interferes with sperm chromatin
integrity is further supported by the modifying
effects of polymorphisms in the AR antigen
(Giwercman et al. 2007). The finding that
POP exposure increases the level of sperm
DNA strand breaks is potentially worrying, as
the risk for transmitting such chromosomal
defects to the offspring are unknown. Animal
INUENDO summary review
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Table 5. Adjusted geometric mean values of semen characteristics according to serum competitive estro-
genic CALUX activity above and below reference values.a
Inuits Europeans
Increased Decreased Increased Decreased 
activity activity activity activity
[> 3.13 RLU [≤ 3.13 RLU [> 3.13 RLU [≤ 3.13 RLU
Semen characteristics (n = 6)] (n = 66)] (n = 88)] (n = 190)]
Conventional semen characteristics
Volume (mL)b,c 3.8 3.1 3.1 3.3
Concentration (million/mL)c 57 56 52 52
Count (million)b,c 211 161 141 172
Normal cells (%) 6.7 6.3 5.4 5.5
Progressive motile (%)c,d 54 52 60 57
Seminal markers of accessory sex gland functionb,c,e
Neutral α-glucosidase (mU/ejaculate) 21 14 22 22
Prostate-speciﬁc antigen (µg/ejaculate) 3,833 2,970 3,489 2,887
Fructose (µmol/ejaculate) 56 45 41 40
Zinc (µmmol/ejaculate) 6.3 4.4 5.8 5.0
Sperm chromatin integrityc,e
DNA fractionation index (%DFI) 4.9 7.1 11.3 11.6
High DNA stainability (%HDS) 10.8 11.1 8.8 9.3
DNA fractionation index [TUNEL (%)] 1.4 2.5 8.3 9.5
Apoptotic markersc,e
Fas positivity (%) 11.4 13.0 14.2 19.0
Bcl-xL positivity (%) 19.8 14.4 14.8 20.0
Y chromosome sperm cells (%) 53.6 51.2 50.9 50.7
Abbreviations: %DFI, percentage of sperm with denaturable DNA, mainly due to DNA damage (Spano et al. 2000); %HDS,
percentage of sperm with high levels of green ﬂuorescence, indicating immature sperm (Spano et al. 2000); n, number of
men; TUNEL, terminal deoxynucleotidyl transferase dUTP nick end-labeling.
aReference 3.13 RLU, the mean value of solvent control samples. bSamples with spillage excluded. cAdjustment by the
logarithm of period of abstinence (day). dSamples with a delay of > 1 hr from collection excluded. eAdjustment by the log-
arithm of age (years).
Table 4. Adjusted geometric mean values of semen characteristics according to serum agonistic estro-
genic CALUX activity above and below average reference values.a
Inuits Europeans
Increased Decreased Increased Decreased 
activity activity activity activity
[> 3.13 RLU  [≤ 3.13 RLU [> 3.13 RLU [≤ 3.13 RLU
Semen characteristics (n = 16)] (n = 56)] (n = 128)] (n = 160)]
Conventional semen characteristics
Volume (mL)b,c 3.9 2.9 3.0 3.4
Concentration (million/mL)c 41 55 51 53
Count (million)b,c 151 146 153 173
Normal cells (%) 6.8 5.3 6.3 5.0
Progressive motile (%)c,d 45 51 58 57
Seminal markers of accessory sex gland functionb,c,e
Neutral α-glucocidase (mU/ejaculate) 15 15 21 23
Prostate-speciﬁc antigen (µg/ejaculate) 2,161 3,364 3,260 2,896
Fructose (µmmol/ejaculate) 51 43 34 44
Zinc (µmmol/ejaculate) 2.7f 5.2 5.7 4.9
Sperm chromatin integrityc,e
DNA fractionation index (%DFI) 4.3f 7.9 11.9 11.3
High DNA stainability (%HDS) 12.4 11.5 8.6 9.3
DNA fractionation index [TUNEL (%)] 1.8 2.5 10.9f 8.5
Apoptotic markersc,e
Fas positivity (%) 11.6 12.9 21.2 16.0
Bcl-xL positivity (%) 7.7 16.8 17.3 20.5
Y chromosome sperm cells (%) 51.2 51.7 51.0 50.7
Abbreviations: %DFI, percentage of sperm with denaturable DNA, mainly due to DNA damage (Spano et al. 2000); %HDS,
percentage of sperm with high levels of green ﬂuorescence, indicating immature sperm (Spano et al. 2000); n, number of
men; TUNEL, terminal deoxynucleotidyl transferase dUTP nick end-labeling.
aReference 3.13 RLU, the mean value of solvent control samples. bSamples with spillage excluded. cAdjustment by the
logarithm of period of abstinence (day). dSamples with a delay of > 1 hr from collection excluded. eAdjustment by the log-
arithm of age (years). fIndicates p < 0.05 for increased versus decreased activity.studies have shown that epigenetic changes in
the sperm DNA, evoked by in utero exposure to
vinclozoline, may pass to and cause infertility
in, at least, three subsequent generations
(Anway et al. 2005). Further research is war-
ranted to understand why Inuits have better
sperm chromatin integrity than Europeans and
why POPs are impairing chromatin integrity in
Europeans but not among Inuits. 
Impact on fertility. Sperm count, mor-
phology, motility, and chromatin integrity are
all reliable and independent indicators of male
fecundity (Bonde et al. 1998; Spano et al.
2000). The INUENDO studies demonstrated
effects related to serum levels of POPs for
three of these biological markers—most con-
sistently for sperm motility. Nevertheless, the
INUENDO study revealed no indications of
delayed conception related to male or female
POP serum levels except in Inuits where
fecundability was reduced by 30% among the
high-level-exposed groups. This ﬁnding was of
borderline statistical signiﬁcance and without
strong exposure–response relationships but
withstood a comprehensive analysis of poten-
tial bias and confounding factors including age
and self-reported urogenital diseases. It is hard
to explain why POPs interfere with fertility in
only one of the four study groups. Neither
exposure characteristcis nor POP-related
effects on male biomarkers of fecundity offer
any clear solutions to this enigma. To our
knowledge, there are no comparable studies
on fertility related to POP exposure among
Inuit people, and the evidence from studies of
other populations is conflicting (Toft et al.
2004). If not caused by bias inherent in the
TTP methodology (Olsen et al. 1998) or
residual confounding that escaped recogni-
tion, yet unknown gene–environement inter-
actions should be identiﬁed in future research.
Internal validity issues. The strengths of
the INUENDO study include large exposure
contrasts and large sample sizes relative to most
end points, adherence to uniform design, pro-
tocol and data collection procedures, individ-
ual biological exposure markers, indicators of
integrated xenohormone and dioxin-like
actions, inclusion of a wide range of established
and novel reproductive end points, analysis of
selected AR polymorphisms, centralized data
management and laboratory analyses with
internal and external quality control, and an
agreed upon protocol for the data analysis.
Several limitations must also be addressed.
Few highly specific hypotheses were stated
a priori, for example, whether PCBs or
p,p´-DDE were to be considered the most
important risk factor for the various reproduc-
tive end points. The same applies for the three
CALUX assays, which represent a large range
of possible risk-factor scenarios. It is important
to acknowledge that most analyses were explo-
rative. Multiple comparisons may constitute a
serious risk for data-induced and post hoc inter-
pretation of random associations (Smith 2001;
Smith and Ebrahim 2002). Magnitude and
statistical strength of associations, exposure–
response relationships, gene polymorphisms,
and biological plausibility has been considered
throughout to help distinguish real from spuri-
ous associations. Another option to evaluate
internal validity was to request consistent asso-
ciations across the four study regions before
assigning high credibility to the findings.
Although still important, the obvious hetero-
geneity among regions with respect to POP
and xenobiotic CALUX exposure profiles
makes this “consistency-approach” less power-
ful than ﬁrst anticipated. Systematic differences
among regions in the genetic make-up that
regulates metabolism of xenobiotics and repro-
ductive functioning add further difﬁculties to
the interpretation of heterogeneous associa-
tions. Even if in many aspects still elusive, envi-
ronment–environment, gene–environment,
and gene–gene interactions can play important
roles in determining the relationship between
exposure to environmental chemicals such as
POPs and associated risks to human health
and reproduction. Nevertheless, few disagree
that associations that consistently survive back-
ground variation and heterogeneity, such as the
relation between PCB and sperm motility, are
more likely to be real. Furthermore, studies of
associations stratified on relevant gene poly-
morphism may be important tools to advance
knowledge in the ﬁeld. Thus, the analyses of
androgen gene polymorphisms in the
INUENDO populations have for the ﬁrst time
demonstrated associations compatible with
genetic modiﬁcation of POP-related effects on
male reproductive health.
Potential confounding factors were
addressed systematically in all analyses accord-
ing to a uniform protocol. Investigators con-
sidered well-established determinants as well
as a number of hypothetical risk factors.
Important determinants of the various out-
comes may still escape adequate control
because at present and to our best knowledge,
they are unknown. Finally, the strong correla-
tion between CB-153 and p,p´-DDE among
Inuits and Swedish ﬁshermen precludes alloca-
tion of effects to one or the other POP. Much
weaker correlations yet large exposure ranges
in the Warsaw and Kharkiv samples can, to
some extent, resolve this problem. 
External validity issues. The sampling
frame in three of the four regions was preg-
nant women and their partners. This should
not be considered an important limitation to
the external validity of all core studies. The
couples enrolled consecutively also include
those in the clinical setting who are labeled
infertile, namely, those couples that took
> 1 year to conceive. Approximately 15–20%
of the “fertile” couples enrolled in this project
would have been classified as infertile in the
clinical terminology. Only a small minority of
sterile couples are not represented in the
database. This is not a problem unless the
exposures being studied have an on–off effect,
which is very unlikely (Baird 1988; Olsen
1999; Olsen et al. 1998). Among the few
known human reproductive toxicants, tobacco
smoking has been demonstrated with equal
efﬁciency in pregnancy and population-based
studies (Bolumar et al. 1996). Thus, the selec-
tion of pregnant women and their spouses for
this study is not expected to reduce the
chance of detecting the effects of POP on
reproductive function. 
There are several pieces of evidence that
indicate reproductive organs are more sensitive
to detrimental effects of chemicals during crit-
ical periods of fetal and postnatal development
than during adult life (e.g,, Anas et al. 2005).
It is therefore important to acknowledge that
the research reviewed in this article does not
explicitly address fetal exposures.
Conclusion
The INUENDO study indicates that POPs
may interfere with adult male reproductive
function without major impact on fertility and
sperm counts. However, subsets of men with
speciﬁc polymorphisms in the AR gene seem
more vulnerable. It is unknown if POP interfer-
ence with sperm chromatin integrity and sperm
DNA may have health consequences in the off-
spring. PCBs seem more to blame than DDT.
No-effect thresholds could not be established.
Findings provided limited direct evidence of
xenobiotic disruption of the endocrine regula-
tion. Further research is needed into POP-
related effects on sperm chromatin integrity
and epididymal function that include modify-
ing effects related to AR polymorphisms. 
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